EBV-positive Nasopharyngeal Carcinoma
2 clinical trials · Condition
◉ Watch EBV-positive Nasopharyngeal Carcinoma
| Record | Firm | Date |
|---|---|---|
| TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC (NCT02065362) | Baylor College of Medicine | 2015-02-01 |
Track EBV-positive Nasopharyngeal Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.